Free beta access. 5 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

Vaccine Nationalism good – cooperation empirically fails

John Kampfner, 6-30-2021 Executive Director, UK in the World Programme, https://www.chathamhouse.org/2021/06/vaccine-competition-may-now-be-worlds-best-bet, "Vaccine competition may now be the world’s best bet," Chatham House – International Affairs Think Tank (ermo/sms, Acc:6-19-2022)

Relations between the major powers are at their worst for decades with cooperation thin on the ground, and COVID-19 having deepened suspicions further.

In April, the US Senate passed the Strategic Competition Act with bipartisan support, promising to ‘counter the malign influence of the Chinese Communist Party globally’. In front of his American counterpart, China’s top foreign policy official denounced the effrontery of those who ‘smear’ Chinese democracy. Joe Biden calls Vladimir Putin ‘a killer’, while the Kremlin has put the US at the top of its list of unfriendly countries. Tension between China and India is high, the EU and UK are involved in repeated spats. Competition and mistrust are everywhere.

Far from producing greater collaboration in adversity, COVID-19 has exacerbated global rivalries. Given that the tensions long pre-dated the pandemic and are unlikely to improve any time soon, it is hard to see how the major powers can be persuaded to cooperate better to tackle this crisis. Coronavirus is just the first test. Other crises will follow.

President Biden calls the relationship with China ‘naturally competitive, sometimes adversarial and, on key issues, necessarily collaborative’. Managing these competing impulses is proving difficult to navigate. One route is the established one, focusing on international institutions and multilateral groups to tackle the big global challenges. In times of tension they have a restraining role; in times of cooperation, they can do so much more.

Yet, if the disappointing results of the G7 are anything to go by, expectations should be managed even lower than they are already. But there is another way. The present atmosphere of intense competition can actually be exploited to the advantage of developing economies* .

Vaccine competition and the early hopes

A few weeks into the crisis, Ricardo Lagos, former president of Chile and a member of the Elders group of international leaders wrote: ‘Hopefully the international institutions will rise to the challenge of responding to this pandemic with the force that it demands, because this crisis will not be overcome by defeating the disease in any one country alone, but by guaranteeing an end to the affliction throughout the world.’

The first reaction of nation states was to protect their own, hoard, close borders – and indulge in nationalist points-scoring.

This has been a story of extraordinary scientific success and extraordinary political failure.

Robert Yates, Director, Global Health Programme; Executive Director, Centre for Universal Health, Chatham House

The more the US and its allies blamed China, both for the outbreak in Wuhan and for what many considered to be a cover-up, and the more China refused to provide the necessary access or information, the more distrustful and disjointed the global response became.

The final year of Donald Trump’s ‘America First’ presidency was characterized by a COVID-19 policy of denial, denigration of science and, at that point, the world’s highest infection rate. The president launched repeated broadsides against the World Health Organization (WHO), denouncing its Director General Tedros Ghebreyesus as a ‘puppet’ of China; he announced the termination of the US’s WHO membership and $400m annual payment, putting its finances in peril just at a time when the organization was most needed. Trump’s approach was borne partly of ideology, partly of a need to create a distraction from his administration’s incompetence.

Across the rich world, governments floundered in their initial response* .

The medical and health community rallied early, creating an initiative designed to distribute vaccines, even as they were still in the early stage of development. The aim of COVAX was to produce and make available two billion vaccines by the end of 2021. ‘No-one is safe until everyone is safe’ became the mantra of collaboration.

Solidarity was not the problem among the organizations – Gavi, the global vaccine alliance, and the Coalition for Epidemic Preparedness Innovations (CEPI) worked with the WHO to get access to the COVID -19 Tools Accelerator, ACT-A, up and running.

COVAX was heralded as the ‘only truly global solution’, but it was a mix of ambition and acknowledgement of the limited commitment of the big powers to collaborate to vaccinate the world. Still, vaccinating ‘the priority fifth’ of the world’s population is better than nothing.

Sign in to recut, update, or save this card.